Skip to main content
Premium Trial:

Request an Annual Quote

Microba, Psomagen Partner to Launch Microbiome Test in US

NEW YORK — Australian biotech firm Microba said today that it has partnered with Macrogen subsidiary Psomagen to introduce a microbiome analysis test in the US.

Microba recently launched a direct-to-consumer service in Australia called Insight, which uses shotgun metagenomics to analyze customers' gut microbiomes and generate a personalized report. Under the terms of the deal, Psomagen will introduce a microbiome test based on Microba's technologies in the US before the end of the year.

Additional terms were not disclosed.

The partnership represents the latest step in an ongoing alliance between Microba and Rockville, Maryland-based Psomagen, a recently renamed subsidiary of South Korea's Macrogen. In March, Microba began working with Macrogen to develop microbiome research services for international markets. A few months later, Macrogen made a $2.8 million investment in Microba.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.